{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"deafness-encephaloneuropathy-obesity-valvulopathy","columns":[{"gene":"","key":"population-9a2f41413c2dc349fb48","label":"Coenzyme Q10 deficiency, primary, 2","mondoId":"MONDO:0013837","onsetQualifier":null,"originColumnKey":"MONDO:0013837/OMIM:614651","originalViews":[{"key":"MONDO:0013837/OMIM:614651","label":"Coenzyme Q10 deficiency, primary, 2","scopeLabel":"OMIM:614651","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["07bb7a815df25fa97bac74d6995bf88a05a9bcc5d7f7ffd6076423cd930fc92c","1cdfaccd37468332346ed5f721695363e345657b7f56d0f5c25d1284654dff62","25de2dc58600c1d38c93414466ca9dfe7c006f992f828e32054a8266dc7ede98","2e9d3155dfed9dbc5bf0467d4a416f3291318fdabde0cfe7e791dd72c083c6d6","6406d5cd61d957bc547546ae9802a0afdc3332006671d939b788493b895c6c1b","6b80c38ba9cbde6b7f9532f807a2988b7d7221d35f18d38062644875b5780383","6db43ad06481d895f9d51a0e087f0d54e09b007c44f980cdfafe9599db5d5840","7edf655568670d9006e6c794458c7977cf97a939a2bb65443ed1e05586d98fea","81b904811c2fb144306e15058a940271bb9b1e44153d2b4118207b9f55fc4703","a4bd855e35e985fcb81be5669526525c472bfdc9d7652f99bb80b06acfe0427b","b27d0d61ebc54ed06a3f7b49439fbf2f1326269f1a78fe664fc448f3b5197657","bda4512b2980326a0f62665d7b6d88c53197177df933b6ae731bb9bca8cfabc2","ec531949137cb6bc8267ae305d84ad850f7268164083790b074c31adaf97658e","ee605237ac2427ef6fc8c23b4943dddac02afbc19ecf676081ba755fb8a2b7b7","f4c5503f2428026be73515b809493ce849dc911431989218591923ee5cd59e09"],"recordQualifiers":{},"scopeLabel":"OMIM:614651","sourceIds":["OMIM:614651"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-9a2f41413c2dc349fb48"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001659","HP:0001284","HP:0100739","HP:0032653","HP:0000365","HP:0002151","HP:0033505"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":15,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":15,"sourceGroups":{"published":15}},"features":[{"hpoId":"HP:0001659","label":"Aortic regurgitation","primary":true},{"hpoId":"HP:0001284","label":"Areflexia","primary":true},{"hpoId":"HP:0100739","label":"Bulimia","primary":true},{"hpoId":"HP:0032653","label":"Elevated lactate:pyruvate ratio","primary":true},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":true},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":true},{"hpoId":"HP:0033505","label":"Livedo reticularis","primary":true},{"hpoId":"HP:0000256","label":"Macrocephaly","primary":false},{"hpoId":"HP:0001256","label":"Mild intellectual disability","primary":false},{"hpoId":"HP:0001653","label":"Mitral regurgitation","primary":false},{"hpoId":"HP:0001513","label":"Obesity","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0025502","label":"Overweight","primary":false},{"hpoId":"HP:0009830","label":"Peripheral neuropathy","primary":false},{"hpoId":"HP:0002092","label":"Pulmonary arterial hypertension","primary":false}],"ledeHtml":"Deafness-encephaloneuropathy-obesity-valvulopathy syndrome is a rare mitochondrial disease with marked clinical variability typically characterized by encephalomyopathy, kidney disease (nephrotic syndrome), optic atrophy, early-onset deafness, pancytopenia, obesity, and cardiac disease (valvulopathy). Additionally, macrocephaly, intellectual disability, hyperlactatemia, elevated lactate/pyruvate ratio, insulin-dependent diabetes, livedo reticularis, liver dysfunction and seizures have also been associated.","mondoId":"MONDO:0013837","node":{"canonicalSlug":"deafness-encephaloneuropathy-obesity-valvulopathy","comparisons":[{"documentSha256":"8baa917da54762875bb00390014b88abd3ca360f1a91d307d54863e5e6fdb938","key":"legacy-coenzyme-q10-deficiency","kind":"legacy","label":"coenzyme Q10 deficiency","memberIds":["MONDO:0011829","MONDO:0012784","MONDO:0013837","MONDO:0013838","MONDO:0013840","MONDO:0014562","MONDO:0014754","MONDO:0018151","MONDO:0033615"],"mondoId":"MONDO:0018151","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/coenzyme-q10-deficiency.8baa917da54762875bb00390014b88abd3ca360f1a91d307d54863e5e6fdb938.json"},{"documentSha256":"fbf9fe5c070b56acd0cf116994a8fc8d0eb34f5da4ee628bf651342272247406","key":"expanded-coenzyme-q10-deficiency","kind":"expanded","label":"coenzyme Q10 deficiency","memberIds":["MONDO:0011829","MONDO:0012784","MONDO:0013836","MONDO:0013837","MONDO:0013838","MONDO:0013840","MONDO:0014562","MONDO:0014754","MONDO:0018151","MONDO:0033615","MONDO:0957874"],"mondoId":"MONDO:0018151","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-fbf9fe5c070b56acd0cf.fbf9fe5c070b56acd0cf116994a8fc8d0eb34f5da4ee628bf651342272247406.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Deafness-encephaloneuropathy-obesity-valvulopathy syndrome","originalSourceId":"ORPHA:254898","paragraphs":["Deafness-encephaloneuropathy-obesity-valvulopathy syndrome is a rare mitochondrial disease with marked clinical variability typically characterized by encephalomyopathy, kidney disease (nephrotic syndrome), optic atrophy, early-onset deafness, pancytopenia, obesity, and cardiac disease (valvulopathy). Additionally, macrocephaly, intellectual disability, hyperlactatemia, elevated lactate/pyruvate ratio, insulin-dependent diabetes, livedo reticularis, liver dysfunction and seizures have also been associated."],"rawAttribution":"MONDO:0013837","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:18Z","upstream":"MONDO:0013837","url":"https://rarediseases.info.nih.gov/diseases/17230"},"ownColumnKeys":["population-9a2f41413c2dc349fb48"],"publication":"published","relationships":[{"kind":"parent","label":"coenzyme Q10 deficiency","mondoId":"MONDO:0018151","slug":"coenzyme-q10-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/primary-coenzyme-q10-deficiency"}],"translation":"published"},"records":[{"frequencyKind":"count","key":"07bb7a815df25fa97bac74d6995bf88a05a9bcc5d7f7ffd6076423cd930fc92c","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0002092","is_excluded":false,"label":"Pulmonary arterial hypertension","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1cdfaccd37468332346ed5f721695363e345657b7f56d0f5c25d1284654dff62","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000256","is_excluded":false,"label":"Macrocephaly","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"25de2dc58600c1d38c93414466ca9dfe7c006f992f828e32054a8266dc7ede98","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0032653","is_excluded":false,"label":"Elevated lactate:pyruvate ratio","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2e9d3155dfed9dbc5bf0467d4a416f3291318fdabde0cfe7e791dd72c083c6d6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001256","is_excluded":false,"label":"Mild intellectual disability","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6406d5cd61d957bc547546ae9802a0afdc3332006671d939b788493b895c6c1b","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6b80c38ba9cbde6b7f9532f807a2988b7d7221d35f18d38062644875b5780383","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001653","is_excluded":false,"label":"Mitral regurgitation","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6db43ad06481d895f9d51a0e087f0d54e09b007c44f980cdfafe9599db5d5840","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0033505","is_excluded":false,"label":"Livedo reticularis","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7edf655568670d9006e6c794458c7977cf97a939a2bb65443ed1e05586d98fea","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0009830","is_excluded":false,"label":"Peripheral neuropathy","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"81b904811c2fb144306e15058a940271bb9b1e44153d2b4118207b9f55fc4703","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001659","is_excluded":false,"label":"Aortic regurgitation","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a4bd855e35e985fcb81be5669526525c472bfdc9d7652f99bb80b06acfe0427b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0100739","is_excluded":false,"label":"Bulimia","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"b27d0d61ebc54ed06a3f7b49439fbf2f1326269f1a78fe664fc448f3b5197657","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bda4512b2980326a0f62665d7b6d88c53197177df933b6ae731bb9bca8cfabc2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ec531949137cb6bc8267ae305d84ad850f7268164083790b074c31adaf97658e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001284","is_excluded":false,"label":"Areflexia","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ee605237ac2427ef6fc8c23b4943dddac02afbc19ecf676081ba755fb8a2b7b7","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001513","is_excluded":false,"label":"Obesity","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f4c5503f2428026be73515b809493ce849dc911431989218591923ee5cd59e09","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:614651","disease_name":"Coenzyme Q10 deficiency, primary, 2","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0025502","is_excluded":false,"label":"Overweight","onset_id":null,"reference":"PMID:17332895","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17230\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013837\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0013837</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Deafness-encephaloneuropathy-obesity-valvulopathy syndrome is a rare mitochondrial disease with marked clinical variability typically characterized by encephalomyopathy, kidney disease (nephrotic syndrome), optic atrophy, early-onset deafness, pancytopenia, obesity, and cardiac disease (valvulopathy). Additionally, macrocephaly, intellectual disability, hyperlactatemia, elevated lactate/pyruvate ratio, insulin-dependent diabetes, livedo reticularis, liver dysfunction and seizures have also been associated.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/17230\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"deafness-encephaloneuropathy-obesity-valvulopathy","sourceDocuments":[{"name":"GARD: Deafness-encephaloneuropathy-obesity-valvulopathy syndrome","reviewed":null,"source_release":"2026-10-25T03:42:18Z","url":"https://rarediseases.info.nih.gov/diseases/17230"},{"name":"MONDO: deafness-encephaloneuropathy-obesity-valvulopathy syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013837"}],"sourceNote":"","synonyms":["coenzyme Q10 deficiency, primary, 2","coenzyme Q10 deficiency, primary, type 2","COQ10D2","hearing loss-encephaloneuropathy-obesity-valvulopathy syndrome"],"takeawayHtml":"","title":"deafness-encephaloneuropathy-obesity-valvulopathy syndrome"},"schemaVersion":1}
